Zacks Investment Research upgraded shares of ICU Medical, Inc. (NASDAQ:ICUI) from a sell rating to a hold rating in a report issued on Monday.
According to Zacks, “ICU Medical, Inc., together with its wholly-owned subsidiary Budget Medical Products, Inc. is a leader in the development, manufacture and sale of proprietary, disposable medical connection systems for use in intravenous therapy applications. The company’s intravenous connectors are designed to prevent accidental disconnection’s of intravenous lines and to protect healthcare workers and their patients from the spread of infectious diseases such as Hepatitis B and Human Immunodeficiency Virus by significantly reducing the risk of accidental needlesticks. “
Other equities analysts have also issued research reports about the stock. Gabelli reiterated a buy rating on shares of ICU Medical in a research report on Friday, August 11th. BidaskClub upgraded shares of ICU Medical from a hold rating to a buy rating in a research report on Saturday, June 17th. Finally, Sidoti lowered shares of ICU Medical from a buy rating to a neutral rating in a research report on Tuesday, June 20th. One investment analyst has rated the stock with a sell rating, three have assigned a hold rating and one has given a buy rating to the company’s stock. The stock has a consensus rating of Hold and a consensus price target of $193.00.
ICU Medical (ICUI) traded down 0.14% during mid-day trading on Monday, reaching $180.95. 32,031 shares of the company’s stock traded hands. ICU Medical has a 12-month low of $120.93 and a 12-month high of $182.45. The stock has a 50-day moving average price of $172.26 and a 200-day moving average price of $163.56. The stock has a market capitalization of $3.59 billion, a PE ratio of 72.47 and a beta of 0.36.
ICU Medical (NASDAQ:ICUI) last released its quarterly earnings data on Wednesday, August 9th. The medical instruments supplier reported $0.52 EPS for the quarter, missing the Thomson Reuters’ consensus estimate of $0.58 by ($0.06). ICU Medical had a net margin of 6.10% and a return on equity of 7.56%. The business had revenue of $331.51 million for the quarter, compared to the consensus estimate of $318.30 million. During the same quarter last year, the business earned $1.15 EPS. ICU Medical’s revenue for the quarter was up 242.8% compared to the same quarter last year. Equities research analysts expect that ICU Medical will post $4.11 EPS for the current year.
ILLEGAL ACTIVITY WARNING: “ICU Medical, Inc. (ICUI) Upgraded by Zacks Investment Research to Hold” was first published by BBNS and is the sole property of of BBNS. If you are viewing this report on another site, it was stolen and reposted in violation of United States and international trademark and copyright law. The legal version of this report can be viewed at https://baseballnewssource.com/markets/icu-medical-inc-icui-upgraded-by-zacks-investment-research-to-hold/1635275.html.
In other news, VP Virginia Ruth Sanzone sold 1,784 shares of the firm’s stock in a transaction dated Thursday, September 7th. The shares were sold at an average price of $174.47, for a total value of $311,254.48. Following the completion of the sale, the vice president now owns 102 shares in the company, valued at approximately $17,795.94. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director Robert S. Swinney sold 4,477 shares of the firm’s stock in a transaction dated Thursday, July 20th. The stock was sold at an average price of $175.00, for a total transaction of $783,475.00. Following the completion of the sale, the director now owns 23,293 shares of the company’s stock, valued at approximately $4,076,275. The disclosure for this sale can be found here. Insiders sold a total of 212,549 shares of company stock valued at $36,354,740 in the last 90 days. Company insiders own 15.90% of the company’s stock.
A number of hedge funds have recently bought and sold shares of ICUI. Creative Planning increased its stake in ICU Medical by 315.6% in the 1st quarter. Creative Planning now owns 665 shares of the medical instruments supplier’s stock worth $102,000 after buying an additional 505 shares during the period. Janney Montgomery Scott LLC increased its stake in ICU Medical by 0.4% in the 1st quarter. Janney Montgomery Scott LLC now owns 1,607 shares of the medical instruments supplier’s stock worth $245,000 after buying an additional 7 shares during the period. Great West Life Assurance Co. Can increased its stake in ICU Medical by 6.5% in the 1st quarter. Great West Life Assurance Co. Can now owns 21,104 shares of the medical instruments supplier’s stock worth $3,222,000 after buying an additional 1,280 shares during the period. State Board of Administration of Florida Retirement System increased its stake in ICU Medical by 1.9% in the 1st quarter. State Board of Administration of Florida Retirement System now owns 7,080 shares of the medical instruments supplier’s stock worth $1,081,000 after buying an additional 130 shares during the period. Finally, First Trust Advisors LP increased its stake in ICU Medical by 42.0% in the 1st quarter. First Trust Advisors LP now owns 10,188 shares of the medical instruments supplier’s stock worth $1,556,000 after buying an additional 3,013 shares during the period. 78.13% of the stock is currently owned by institutional investors.
ICU Medical Company Profile
ICU Medical, Inc is engaged in the development, manufacture and sales of medical devices used in infusion therapy, oncology and critical care applications. The Company’s product line includes needlefree connection devices, custom infusion sets, closed system transfer devices (CSTD) for the handling of hazardous drugs, advanced sensor catheters, needlefree closed blood sampling systems, disposable pressure transducer systems and hemodynamic monitoring systems.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for ICU Medical Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ICU Medical Inc. and related companies with our FREE daily email newsletter.